Developing Genetic Therapies for Ultra-Rare Diseases: Key Considerations

Time: 11:00 am
day: Pre-conference focus day


• Development in areas with little to no current treatment options
• Establishing good working relationships with patient groups
• Engaging early on to inform early education, registry creation, and clinical trial readiness including data returns & clinical outcome measures